DRKS00000269RecruitingPhase 4
Gabapentin as symptomatic therapy of cerebellar ataxia in degenerative and inflammatory CNS-disease - GABATAX
FakultätsleitungCharité - Universitätsmedizin Berlin0 sites72 target enrollmentStarted: April 7, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
- Enrollment
- 72
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 75 Years (—)
- Sex
- All
Inclusion Criteria
- •patient written consent
- •- age 18-75 years
- •- cerebellar ataxia in patients with multiple sclerosis since at least 3 months, in patients with degenerative cerebellar ataxia since at least 1 year
- •- for women before menopause: negative pregrancy test and highly effective contraception method applied
Exclusion Criteria
- •- pregnancy and lactation
- •- all contraindications against the drug or the placebo ingredients
- •- medication with morphin, pregabaline, naproxen
- •- gabapentine-treatment within the last month
- •- forced hospitalization
- •- alcohol abuse within the past 10 years
- •- acute or chronic pancreatitis
- •- renal insufficiency
- •- liver insufficiency
- •- unability to walk even with support
- •- participation in another treatment trial up to 2 months before and during the participation in GABATAX
Investigators
Similar Trials
Active, not recruiting
Phase 1
Effect of gabapentine as symptomatic therapy for cerebellar ataxia in degenerative and inflammatory CNS-disease - GABATAXEUCTR2008-005167-33-DECharité University Medicine Berlin
Not yet recruiting
Phase 3
The efficacy of Gabapentin in chronic refractory cough in Interstitial Lung DiseaseCTRI/2024/07/071040one
Completed
Phase 3
The role of Gabapentin in the treatment of refractory chronic dry cough.chronic coughRespiratory - Other respiratory disorders / diseasesACTRN12608000248369Hunter New England Area Health Service56
Recruiting
Phase 3
Is there a role of Gabapentin as Monotherapy in Dystonic Cerebral Palsy?CTRI/2018/11/016262Jaslok Hospital and Research Center
Recruiting
Phase 3
Is there a role of Gabapentin as Add-on therapy in Dystonic Cerebral Palsy?CTRI/2018/12/016689Jaslok Hospital and Research Center